Share-Based Compensation and Capital Stock - Summary of Change in Stock-Based Award Activity (Details)	3 Months Ended
	Mar. 31, 2022 $ / shares shares
Stock Options
Options
Outstanding, beginning balance (in shares) | shares	910,944
Granted (in shares) | shares	155,774
Performance-based leveraging (in shares) | shares	0
Exercised/vested (in shares) | shares	(41,054)
Expired (in shares) | shares	0
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	1,025,664
Options exercisable, ending balance (in shares) | shares	549,980
Weighted Average Exercise Price
Beginning balance - weighted average exercise price (in usd per share) | $ / shares	$ 83.14
Granted - weighted average exercise price (in usd per share) | $ / shares	146.68
Performance-based leveraging - weighted average exercise price (in usd per share) | $ / shares	0
Exercised/vested - weighted average exercise price (in usd per share) | $ / shares	53.86
Expired - weighted average exercise price (in usd per share) | $ / shares	0
Forfeited - weighted average exercise price (in usd per share) | $ / shares	0
Ending balance - weighted average exercise price (in usd per share) | $ / shares	93.96
Options exercisable, ending balance - weighted average exercise price (in usd per share) | $ / shares	$ 76.12
Weighted Average Remaining Contractual Term
Weighted average remaining contractual term - outstanding, ending balance	6 years 2 months 12 days
Weighted average remaining contractual term - options exercisable, ending balance	4 years
Restricted Stock
Restricted Stock, Weighted Average Grant Date Fair Value
Outstanding, beginning balance (in shares) | shares	236,599
Granted (in shares) | shares	241,833
Performance-based leveraging (in shares) | shares	0
Exercised/vested (in shares) | shares	(76,229)
Expired (in shares) | shares	0
Forfeited (in shares) | shares	(1,407)
Outstanding, ending balance (in shares) | shares	400,796
Restricted Stock and Performance vested Restricted Stock Units
Outstanding, beginning balance - weighted average grant date fair value (in usd per share) | $ / shares	$ 92.60
Granted - weighted average grant date fair value (in usd per share) | $ / shares	146.68
Performance-based leveraging - weighted average grant date fair value (in usd per share) | $ / shares	0
Exercised/vested - weighted average grant date fair value (in usd per share) | $ / shares	87.90
Expired - weighted average grant date fair value (in usd per share) | $ / shares	0
Forfeited - weighted average grant date fair value (in usd per share) | $ / shares	94.19
Outstanding, ending balance - weighted average grant date fair value (in usd per share) | $ / shares	$ 126.12
Performance Vested Restricted Stock Units
Restricted Stock, Weighted Average Grant Date Fair Value
Outstanding, beginning balance (in shares) | shares	412,642
Granted (in shares) | shares	111,585
Performance-based leveraging (in shares) | shares	12,280
Exercised/vested (in shares) | shares	0
Expired (in shares) | shares	(78,370)
Forfeited (in shares) | shares	(194)
Outstanding, ending balance (in shares) | shares	457,943
Restricted Stock and Performance vested Restricted Stock Units
Outstanding, beginning balance - weighted average grant date fair value (in usd per share) | $ / shares	$ 114.70
Granted - weighted average grant date fair value (in usd per share) | $ / shares	181.91
Performance-based leveraging - weighted average grant date fair value (in usd per share) | $ / shares	81.55
Exercised/vested - weighted average grant date fair value (in usd per share) | $ / shares	0
Expired - weighted average grant date fair value (in usd per share) | $ / shares	81.15
Forfeited - weighted average grant date fair value (in usd per share) | $ / shares	114.36
Outstanding, ending balance - weighted average grant date fair value (in usd per share) | $ / shares	$ 135.65